← All companies
PBH
Prestige Consumer Healthcare Inc.
$51.92
+1.97 +3.94%
Key statistics
from XBRL data in SEC filingsMarket cap
$2.46B
Revenue (TTM)
$1.09B
Net income (TTM)
$190M
EPS (TTM)
$3.91
P/E ratio
13.3
Dividend yield
—
Free cash flow
$246M
Cash
$63.9M
Total assets
$3.49B
Gross margin
54.7%
52-week range
$42.62 – $75.31
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Entered a material agreement; Took on a direct financial obligation
Jul 15, 2026
8-K/A
Jul 9, 2026
8-K
Entered a material agreement; Took on a direct financial obligation; Regulation FD disclosure
Jul 6, 2026
8-K/A
Jun 30, 2026
8-K
Entered a material agreement; Completed an acquisition or disposition; Took on a direct financial obligation; Other events
Jun 16, 2026
10-K
Fiscal year ended 2026-03-31
May 14, 2026
8-K
Entered a material agreement; Results of operations (earnings release); Regulation FD disclosure
May 13, 2026
8-K
Entered a material agreement; Regulation FD disclosure; Other events
Mar 20, 2026
10-Q
Quarter ended 2025-12-31
Feb 5, 2026
8-K
Results of operations (earnings release); Regulation FD disclosure
Feb 5, 2026
10-Q
Quarter ended 2025-09-30
Nov 6, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
Nov 6, 2025
10-Q
Quarter ended 2025-06-30
Aug 7, 2025
8-K
Entered a material agreement; Results of operations (earnings release); Regulation FD disclosure
Aug 7, 2025
10-K
Fiscal year ended 2025-03-31
May 9, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
May 8, 2025
10-Q
Quarter ended 2024-12-31
Feb 6, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
Feb 6, 2025
8-K
Director or officer change
Jan 6, 2025
10-Q
Quarter ended 2024-09-30
Nov 7, 2024
8-K
Results of operations (earnings release); Regulation FD disclosure
Nov 7, 2024
10-Q
Quarter ended 2024-06-30
Aug 8, 2024
8-K
Results of operations (earnings release); Regulation FD disclosure
Aug 8, 2024
10-K
Fiscal year ended 2024-03-31
May 15, 2024
8-K
Results of operations (earnings release); Regulation FD disclosure; Other events
May 14, 2024
8-K
Director or officer change
May 8, 2024
10-Q
Quarter ended 2023-12-31
Feb 8, 2024
8-K
Results of operations (earnings release); Regulation FD disclosure
Feb 8, 2024
8-K
Entered a material agreement; Took on a direct financial obligation
Dec 13, 2023
10-Q
Quarter ended 2023-09-30
Nov 2, 2023
8-K
Results of operations (earnings release); Regulation FD disclosure
Nov 2, 2023
10-Q
Quarter ended 2023-06-30
Aug 3, 2023
8-K
Results of operations (earnings release); Regulation FD disclosure
Aug 3, 2023
10-K
Fiscal year ended 2023-03-31
May 5, 2023
8-K
Results of operations (earnings release); Regulation FD disclosure; Other events
May 4, 2023
10-Q
Quarter ended 2022-12-31
Feb 2, 2023
8-K
Results of operations (earnings release); Regulation FD disclosure
Feb 2, 2023
10-Q
Quarter ended 2022-09-30
Nov 3, 2022
8-K
Results of operations (earnings release); Regulation FD disclosure
Nov 3, 2022
10-Q
Quarter ended 2022-06-30
Aug 4, 2022